Position in DHR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$880,208
+$53,552 QoQ
Shares Held
4,621
+6.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,141
of 2,098 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Beaumont Financial Advisors, LLC holds $1,902,481 across 2 Diagnostics & Research names. DHR ranks #2 (46.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,039 | $1,022,273 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
4,621 | $880,208 |
All Filings in DHR
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $880,208 | 4,621 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $826,656 | 4,360 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,022,356 | 4,466 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $881,265 | 4,445 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $679,932 | 3,442 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $699,255 | 3,411 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $679,008 | 2,958 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $516,005 | 1,856 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $651,608 | 2,608 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $639,283 | 2,560 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $588,297 | 2,543 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $625,956 | 2,523 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $11,333,042 | 47,221 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $11,973,411 | 47,506 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $12,863,844 | 48,466 | Shares | Sole | 2023-01-25 | |
| No filing history on record for this holder in this stock. | ||||||